Helen Tremlett is a Cross Autoimmunity Prevention Symposium Attendee

Dr. Tremlett is a neuroepidemiologist whose research defines the prodromal phase of multiple sclerosis and the factors that shape disease risk, progression and treatment response. Through large-scale, multidisciplinary studies spanning pharmacoepidemiology, genetics and the gut microbiome, she advances strategies for therapeutic intervention, refined risk assessment, and improved long-term outcomes in immune-mediated neurologic disease.